STOCK TITAN

Jane Henderson sells 6,000 APGE restricted shares (NASDAQ: APGE)

Filing Impact
(Neutral)
Filing Sentiment
(Neutral)
Form Type
144

Rhea-AI Filing Summary

APGE reported a Form 144 notifying the sale of 6,000 restricted shares of Common Stock by Jane Henderson. The filing lists four 10b5-1 sales across 01/02/2026, 01/06/2026, 02/02/2026, and 03/02/2026 with per-trade share counts of 6,000, 2,000, 2,000 and 2,000 respectively and reported proceeds per trade in the filing.

Positive

  • None.

Negative

  • None.

Insights

Routine Form 144 reports structured 10b5-1 sales of restricted shares.

The filing documents the sale of restricted Common Stock under a disclosed 10b5-1 plan by Jane Henderson; the listed securities to be sold total 6,000 shares tied to a Restricted Stock Award dated 02/01/2023.

Timing and proceeds are shown per trade; cash-flow treatment is the selling holder's receipts. This is a standard Section 16 disposition filing and does not by itself imply regulatory noncompliance.

144: Filer Information

144: Issuer Information

144: Securities Information



Furnish the following information with respect to the acquisition of the securities to be sold and with respect to the payment of all or any part of the purchase price or other consideration therefor:

144: Securities To Be Sold


* If the securities were purchased and full payment therefor was not made in cash at the time of purchase, explain in the table or in a note thereto the nature of the consideration given. If the consideration consisted of any note or other obligation, or if payment was made in installments describe the arrangement and state when the note or other obligation was discharged in full or the last installment paid.



Furnish the following information as to all securities of the issuer sold during the past 3 months by the person for whose account the securities are to be sold.

144: Securities Sold During The Past 3 Months

144: Remarks and Signature

FAQ

What did APGE's Form 144 disclose about the sales?

The filing discloses a Form 144 by Jane Henderson reporting the sale of 6,000 restricted shares. It lists four 10b5-1 transactions dated 01/02/2026, 01/06/2026, 02/02/2026, and 03/02/2026 with proceeds reported per trade.

Who conducted the sales reported in the APGE Form 144?

The sales were reported by Jane Henderson and executed under a 10b5-1 plan. The filing attributes the securities to a Restricted Stock Award dated 02/01/2023 and shows the sales as dispositions of those restricted shares.

How many shares were listed as "securities to be sold" for APGE?

The filing lists 6,000 shares of Common Stock as the securities to be sold, associated with a Restricted Stock Award dated 02/01/2023. The filing pairs that listed amount with the per-trade transactions shown in the sale history.

Do the Form 144 entries show how proceeds were handled?

The filing reports proceeds for each 10b5-1 sale as individual trade amounts next to the dates and share counts. It does not state company receipt of proceeds; proceeds are reported as part of the selling-holder transaction lines in the excerpt.
Apogee Therapeutics Inc

NASDAQ:APGE

View APGE Stock Overview

APGE Rankings

APGE Latest News

APGE Latest SEC Filings

APGE Stock Data

5.03B
50.35M
Biotechnology
Biological Products, (no Diagnostic Substances)
Link
United States
WALTHAM